US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE DE LILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT PASTEUR DE LILLE, CENTRE HOSPITALIER REGIONAL UNIVERSITARIE DE LILLE on Nov. 18 for "Use of antagonists of Th17 cytokines for the treatment of bronchial remodeling in patients suffering from allergic asthma" (French Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,357, issued on Nov. 18, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (Paris), UNIVERSITE DE LILLE (Lille, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), INSTITUT PASTEUR DE LILLE (Lille, France) and CENTRE HOSPITALIER REGIONAL UNIVERSITARIE DE LILLE (Lille, France).

"Use of antagonists of Th17 cytokines for the treatment of bronchial remodeling in patients suffering from allergic asthma" was invented by Anne Tsicopoulos (Lille, France), Saliha Ait Yahia Sended (Lille, France), Julie Nanou (Lille, France), Melodie Boute (Lille, France), Han Vorng (Lille, France) and Cecile Chenivesse (Lille, France).

According to the abstract* ...